The Hatch-Waxman Act of 1984 restores patent term for FDA review time, roughly one day for every two days spent in regulatory process up to a cap, but the restoration becomes less effective the longer review drags on, so effective market life has shrunk to about 8-9 years for many drugs.

factualpending

Speaker

Richard Epstein

Evidence Quote

“the Hatch-Waxman Act... for every 2 days that you are basically tied up in the FDA, you'll get 1 day at the end of the term”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...